University Of Adelaide

Testosterone therapy plus lifestyle intervention was tied to a larger improvement in sexual desire than lifestyle intervention alone among older men with impaired glucose tolerance, according to a secondary analysis of the T4DM trial.

A new analysis in Respiratory Medicine found that about one in eight patients with acute pulmonary embolism also have atrial fibrillation, which was associated with increased short- and long-term mortality.

Compared with placebo, 2 years of testosterone therapy was associated with lower risk for type 2 diabetes among men with impaired glucose tolerance or newly diagnosed diabetes but no hypogonadism, according to trial data.